These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38282793)

  • 1. LncRNA EMX2OS Induces Proliferation, Invasion and Sphere Formation of Ovarian Cancer Cells via Regulating the miR-654-3p/AKT3/PD-L1 Axis [Retraction].
    Cancer Manag Res; 2024; 16():67-68. PubMed ID: 38282793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA EMX2OS Induces Proliferation, Invasion and Sphere Formation of Ovarian Cancer Cells via Regulating the miR-654-3p/AKT3/PD-L1 Axis.
    Duan M; Fang M; Wang C; Wang H; Li M
    Cancer Manag Res; 2020; 12():2141-2154. PubMed ID: 32273754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
    Chen ZH; Cui MY; Zhang HM
    Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis [Retraction].
    Cancer Manag Res; 2024; 16():65-66. PubMed ID: 38282791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0015326 Promotes the Proliferation, Invasion and Migration of Ovarian Cancer Through miR-127-3p/MYB [Retraction].
    Cancer Manag Res; 2021; 13():8553-8554. PubMed ID: 34824549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA
    Cancer Manag Res; 2022; 14():257-258. PubMed ID: 35087287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer [Retraction].
    Onco Targets Ther; 2023; 16():579-580. PubMed ID: 37465588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S; Wang K; Huang X; Zhao Z; Zhao Z
    Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis [Retraction].
    Cancer Manag Res; 2022; 14():2105-2106. PubMed ID: 35769227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis [Retraction].
    Cancer Manag Res; 2023; 15():979-980. PubMed ID: 37693223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG4 promotes malignant biological behaviors and immune escape of colorectal cancer cells by regulating the miR-144-3p/MET axis.
    Zhou N; Chen Y; Yang L; Xu T; Wang F; Chen L; Liu J; Liu G
    Am J Transl Res; 2021; 13(10):11144-11161. PubMed ID: 34786048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction].
    Cancer Manag Res; 2022; 14():3457-3458. PubMed ID: 36545223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
    Xu C; Zhu LX; Sun DM; Yao H; Han DX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction].
    Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
    Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
    Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic Vaccinia Virus-Mediated Antitumor Effect and Cell Proliferation Were Promoted in PTC by Regulating circRNA_103598/miR-23a-3p/IL-6 Axis [Retraction].
    Cancer Manag Res; 2023; 15():977-978. PubMed ID: 37693222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis [Retraction].
    Cancer Manag Res; 2023; 15():1005-1006. PubMed ID: 37727812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone inhibited tumor progression by disrupting the stability of PD-L1 by miR-127-3p/VAMP2 in ovarian cancer.
    Gu Y; Zhang Y; Liu J
    Pak J Pharm Sci; 2022 Jan; 35(1(Special)):393-400. PubMed ID: 35236654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_HIPK3 Knockdown Inhibits Cell Proliferation, Migration and Invasion of Cholangiocarcinoma Partly via Mediating the miR-148a-3p/ULK1 Pathway [Retraction].
    Cancer Manag Res; 2022; 14():1713-1714. PubMed ID: 35592109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.